226 related articles for article (PubMed ID: 2533218)
1. Significance of oestradiol values in IVF-ET under a combined GnRH analogue--desensitization and simultaneous gonadotrophin stimulation for the outcome of pregnancies.
Mettler L; Tavmergen EN
Hum Reprod; 1989 Nov; 4(8 Suppl):59-64. PubMed ID: 2533218
[TBL] [Abstract][Full Text] [Related]
2. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
European and Middle East Orgalutran Study Group
Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
[TBL] [Abstract][Full Text] [Related]
3. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
[TBL] [Abstract][Full Text] [Related]
4. Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.
Wildt L; Diedrich K; van der Ven H; al Hasani S; Hübner H; Klasen R
Hum Reprod; 1986 Jan; 1(1):15-9. PubMed ID: 2971082
[TBL] [Abstract][Full Text] [Related]
5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
6. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
Younis JS; Matilsky M; Radin O; Ben-Ami M
Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
[TBL] [Abstract][Full Text] [Related]
7. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
8. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. III. Proteoglycans.
Franchimont P; Hazee-Hagelstein MT; Hazout A; Gysen P; Salat-Baroux J; Schatz B; Demerle F
Biol Reprod; 1990 Aug; 43(2):183-90. PubMed ID: 2143088
[TBL] [Abstract][Full Text] [Related]
9. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
[TBL] [Abstract][Full Text] [Related]
10. Do analogues of gonadotrophin releasing hormone influence follicular fluid steroid levels, oocyte maturity and fertilization rates?
Tavmergen E; Tavmergen EN; Capanoğlu R
Hum Reprod; 1992 Apr; 7(4):479-82. PubMed ID: 1387881
[TBL] [Abstract][Full Text] [Related]
11. CA-125 concentrations in the serum and pregnancy outcome in IVF cycles.
Brandenberger AW; Bersinger NA; Huber PR; Berger E; Glanzmann P; Birkhaeuser MH
J Assist Reprod Genet; 1998 Jul; 15(6):390-4. PubMed ID: 9673885
[TBL] [Abstract][Full Text] [Related]
12. The utility of a midcycle follicle-stimulating hormone boost in addition to human chorionic gonadotropin for timing of follicle aspiration in unstimulated in vitro fertilization cycles.
Lindheim SR; Sauer MV; Francis MM; Macaso T; Lobo R; Paulson RJ
Gynecol Obstet Invest; 1997; 43(2):76-8. PubMed ID: 9067710
[TBL] [Abstract][Full Text] [Related]
13. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
Gersak K; Meden-Vrtovec H; Tomazevic T
Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
[TBL] [Abstract][Full Text] [Related]
14. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
15. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?
Kyrou D; Popovic-Todorovic B; Fatemi HM; Bourgain C; Haentjens P; Van Landuyt L; Devroey P
Hum Reprod; 2009 Nov; 24(11):2902-9. PubMed ID: 19671625
[TBL] [Abstract][Full Text] [Related]
16. The use of a long-acting gonadotropin-releasing hormone analog(D-Trp-6-LHRH) for improvement of ovarian stimulation in assisted conception programs.
Yang YS; Ho HN; Lien YR; Hwang JL; Melinda S; Lin HR; Lee TY
J Formos Med Assoc; 1991 Nov; 90(11):1081-5. PubMed ID: 1687055
[TBL] [Abstract][Full Text] [Related]
17. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
[TBL] [Abstract][Full Text] [Related]
18. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
[TBL] [Abstract][Full Text] [Related]
19. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
[TBL] [Abstract][Full Text] [Related]
20. Simplification of the method of in vitro fertilization: sonographic measurements of follicular diameter as the sole index of follicular maturity.
Nilsson L; Wikland M; Hamberger L; Hillensjö T; Chari S; Sturm G; Daume E
J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):17-22. PubMed ID: 3926921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
